-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At present, more and more people are starting to receive the new crown vaccine, but breastfeeding women are worried about whether they are suitable for the new crown vaccine.
Whether vaccination will have an adverse effect on the baby.
Recently, a study published online by JAMA showed that within 6 weeks of inoculation with the new crown vaccine, anti-SARS-CoV-2 specific antibodies can be detected in breast milk samples.
Yimaitong compiles and organizes, please do not reprint without authorization.
Dr.
Sivan Haia Perl and colleagues from the Institute of Pulmonary Research at Shamir Medical Center in Zerifen said that the antibodies found in female milk have a strong neutralizing effect and have a potential protective effect on infant infections.
Study Introduction This study conducted a prospective analysis of 504 breast milk samples from 84 Israeli women.
The average age of the women in the study was 34 years old and received two vaccinations against the new crown.
The average monthly age of the female children included was 10.
32 months.
Studies have shown that 2 weeks after the first vaccination, IgA antibodies were found in 61.
8% of breast milk samples.
One or four weeks after the second injection of the new crown vaccine, 86.
1% of the samples were positive.
The researchers said that during the follow-up process, the antibody level will still rise, and 65.
7% of the samples will still be positive after 6 weeks.
The level of anti-SARS-CoV-2 specific IgG antibodies has been low until the 4th week, 91.
7% of the samples were positive; in the 5th and 6th weeks, almost all the samples (97%) were positive.
During the study period, neither the mother nor the baby had any serious adverse events.
However, after the first and second vaccine injections, some women experienced vaccine-related adverse events.
The most common adverse events were local pain, fatigue and fever.
In addition, during the study period, 4 infants developed fever symptoms within the first three weeks.
In addition, a new study published in the American Journal of Obstetrics and Gynecology also shows that the new crown vaccine can protect mothers and babies.
Studies have shown that two weeks after the first injection of the new crown vaccine, breast milk contains new crown antibodies, and the antibodies have been present during the 3-month study and are at a high level.
Yimaitong compiled from: [1] Maternal COVID-19 vaccination may protect breast feeding infants.
Healio.
April 19, 2021.
[2] Jeannie C Kelly, Ebony B Carter, Nandini Raghuraman, et al.
Anti-severeacute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination.
Am J Obstet Gynecol.
2021 Mar31; S0002-9378(21)00211-8.
doi: 10.
1016/j.
ajog.
2021.
03.
031.
Online ahead ofprint.
Whether vaccination will have an adverse effect on the baby.
Recently, a study published online by JAMA showed that within 6 weeks of inoculation with the new crown vaccine, anti-SARS-CoV-2 specific antibodies can be detected in breast milk samples.
Yimaitong compiles and organizes, please do not reprint without authorization.
Dr.
Sivan Haia Perl and colleagues from the Institute of Pulmonary Research at Shamir Medical Center in Zerifen said that the antibodies found in female milk have a strong neutralizing effect and have a potential protective effect on infant infections.
Study Introduction This study conducted a prospective analysis of 504 breast milk samples from 84 Israeli women.
The average age of the women in the study was 34 years old and received two vaccinations against the new crown.
The average monthly age of the female children included was 10.
32 months.
Studies have shown that 2 weeks after the first vaccination, IgA antibodies were found in 61.
8% of breast milk samples.
One or four weeks after the second injection of the new crown vaccine, 86.
1% of the samples were positive.
The researchers said that during the follow-up process, the antibody level will still rise, and 65.
7% of the samples will still be positive after 6 weeks.
The level of anti-SARS-CoV-2 specific IgG antibodies has been low until the 4th week, 91.
7% of the samples were positive; in the 5th and 6th weeks, almost all the samples (97%) were positive.
During the study period, neither the mother nor the baby had any serious adverse events.
However, after the first and second vaccine injections, some women experienced vaccine-related adverse events.
The most common adverse events were local pain, fatigue and fever.
In addition, during the study period, 4 infants developed fever symptoms within the first three weeks.
In addition, a new study published in the American Journal of Obstetrics and Gynecology also shows that the new crown vaccine can protect mothers and babies.
Studies have shown that two weeks after the first injection of the new crown vaccine, breast milk contains new crown antibodies, and the antibodies have been present during the 3-month study and are at a high level.
Yimaitong compiled from: [1] Maternal COVID-19 vaccination may protect breast feeding infants.
Healio.
April 19, 2021.
[2] Jeannie C Kelly, Ebony B Carter, Nandini Raghuraman, et al.
Anti-severeacute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination.
Am J Obstet Gynecol.
2021 Mar31; S0002-9378(21)00211-8.
doi: 10.
1016/j.
ajog.
2021.
03.
031.
Online ahead ofprint.
